Latest News

Ag Growth International (TSX:AFN) has launched a broad overhaul of its business, including executive cuts, North American reorganization, cost actions, and an immediate suspension of its quarterly dividend following recent leadership changes. See our latest analysis for Ag Growth International. The share price closed at CA$17.99 after the announcement, with a 7 day share price return of 24.79% decline and a 30 day share price return of 36.72% decline. The 1 year total shareholder return of...

Pihlajalinna Oyj ( HEL:PIHLIS ) is about to trade ex-dividend in the next three days. The ex-dividend date is usually...

SELLAS Life Sciences Group (SLS) is drawing attention after releasing preclinical data on its CDK9 inhibitor SLS009 in acute myeloid leukemia and filing both a universal shelf registration and a US$150 million at-the-market equity offering. See our latest analysis for SELLAS Life Sciences Group. Those preclinical SLS009 data and the fresh shelf and at the market filing are landing after a sharp run, with the 1 year total shareholder return near 3x and a 52.09% 90 day share price return, even...

Regency Centers (NasdaqGS:REG) has been removed from the FTSE All-World Index. The change affects the company’s presence in a widely followed global equity benchmark used by many index funds. For investors tracking NasdaqGS:REG, the index removal comes with the stock around $74.3 and a value score of 5. The shares show a 9.3% return year to date and 6.2% over the past year, with longer term returns of 37.2% over three years and 57.5% over five years. This type of index change can influence...

Wondering if BGC Group at US$9.40 is pricing in its true potential, or if the market is asking you to pay too much for the growth on offer? The stock has returned 0.1% over the last week and 5.1% year to date, with a 3.3% return over the past year and very large gains over the last 3 and 5 years that set the backdrop for any valuation check today. Recent coverage around BGC Group has kept attention on how the business is positioned within capital markets and how it responds to changing...

Advance Auto Parts renewed its partnership with Team Penske and NASCAR Cup Series champion Ryan Blaney for upcoming NASCAR seasons. The agreement keeps Advance Auto Parts branding on the No. 12 Ford Mustang and at key NASCAR events. The deal includes planned in store appearances and fan engagement events featuring Ryan Blaney. For investors watching NYSE:AAP, this renewed motorsports partnership comes with the stock trading at $51.57. Shares are up 9.6% over the past week, 32.6% year to...

If you are wondering whether IDEX at around US$186.55 is offering fair value or a potential mispricing, you are not alone. The stock has returned 1.3% over the last 7 days, 4.2% year to date and 4.7% over the past year, but this sits alongside a 9.5% decline over the last 30 days and negative 3 and 5 year returns. These mixed returns have kept attention on IDEX, with investors weighing up how its business profile and industry position compare with current expectations. Recent coverage has...

How Distribution Solutions Group's recent share price sets up a valuation check Before getting into detailed valuation work, it helps to understand how Distribution Solutions Group's share price has been behaving and what recent information is shaping expectations. Over the last week, the stock has been relatively steady with a 0.2% decline, but the past month has seen a sharper 12.6% pullback and the year to date return sits at a 7.2% loss, with the last 12 months at a 6.8% loss, even though...

Legence (LGN) has just posted another busy quarter, with Q3 FY 2025 revenue of US$708.0 million and a small loss, as Basic EPS landed at a US$0.02 loss and net income excluding extra items was a US$1.1 million loss. The company has seen revenue move from US$560.8 million in Q3 FY 2024 to US$708.0 million in Q3 FY 2025. Over the trailing 12 months, revenue reached about US$2.4 billion against a trailing 12 month net loss of US$19.8 million, putting the spotlight squarely on scaling margins...

If you are wondering whether Dolby Laboratories at around US$58 per share offers value or a value trap, the starting point is understanding what the current price actually bakes in. The stock has recently pulled back, with returns of 3.8% over 7 days, 9.7% over 30 days and 8.7% year to date, adding to a 25.9% return over 1 year, 28.6% over 3 years and 38.8% over 5 years. Recent coverage around Dolby has focused on its position in audio and visual technologies and how it fits into broader...

Zentalis Pharmaceuticals (ZNTL) has just posted its FY 2025 first half results with total revenue at US$0 million, basic EPS at a loss of US$1.05, and net income excluding extraordinary items at a loss of US$75.2 million. This puts the focus firmly on expense control and cash burn. Over the recent periods, the company has seen revenue move from US$40.6 million in the first half of 2024 to US$26.9 million in the second half of 2024, before dropping to zero in the latest half. Half year basic...

Earlier this week, Formentera Partners and INPEX announced a joint venture to accelerate development of onshore natural gas resources in Australia’s Beetaloo Basin, with INPEX gaining acreage through a staged earn-in to support domestic supply and potential LNG exports. This partnership combines Formentera’s shale development capabilities with INPEX’s LNG project experience, potentially creating a new, scalable gas hub that could influence the company’s long-term resource mix and...

JBS (NYSE:JBS) has been removed from the FTSE All-World Index. The change affects the company’s presence in a major global equity benchmark tracked by many passive funds. The decision may influence how both current and prospective shareholders assess JBS within global portfolios. JBS, trading at $17.03, has seen a return of 19.5% over the past week and 20.1% year to date, with a 3.8% return over the past 30 days. With a value score of 6, the stock sits in a segment of the market that some...

Wondering whether Arch Capital Group at around US$93 per share still offers value, or if most of the opportunity is already reflected in the price? This article focuses squarely on what the current valuation signals might be telling you. The stock has gained 1.2% over the last 7 days, while showing a 6.0% decline over 30 days and a slight 0.5% decline year to date, alongside a 1.7% decline over the last year and longer term returns of 44.8% over 3 years and 149.3% over 5 years. Recent...

Sofina Société Anonyme (ENXTBR:SOF) opened FY 2025 with a weak first half, reporting a loss as basic EPS swung to €11.87 and total revenue came in at a loss of €358.9 million. This comes against a backdrop where the trailing twelve months still show positive EPS of €12.48 and revenue of €486.1 million. Over the past year, the company has seen total revenue move from €587.1 million in 2024 H1 to €844.98 million in 2024 H2 and EPS shift from €16.59 to €24.29 in the same periods, before the...

Sinopharm Group (SEHK:1099) has drawn investor attention after its board proposed a final dividend of CN¥0.69 per share for 2025, totaling about CN¥2.15b, subject to approval at the June 18 AGM. See our latest analysis for Sinopharm Group. The proposed dividend comes after a period where momentum has been mixed, with a 30 day share price return showing a decline of 7.38% and a one year total shareholder return of 15.09%. This suggests recent weakness against a stronger longer term outcome. If...

Foran Mining (TSX:FOM) has updated investors on construction at its McIlvenna Bay project, reporting progress of about 91% and confirming the site remains on schedule and within budget as commissioning continues. See our latest analysis for Foran Mining. At a share price of CA$5.34, Foran Mining has seen a 2.69% 1 day share price return and a 5.74% 7 day share price return. However, the 30 day share price return shows a 23.71% decline, which contrasts with a 43.55% 1 year total shareholder...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

DBV Technologies (ENXTPA:DBV) has put fresh numbers on the table for FY 2025, with third quarter revenue of US$2.8 million and a basic EPS loss of US$0.24 alongside a net income loss of US$33.2 million. Together, these figures provide a clear snapshot of where the business stands today. Over recent quarters, the company has reported revenue of US$0.5 million in Q4 2024, US$0.8 million in Q1 2025, US$1.5 million in Q2 2025 and US$2.8 million in Q3 2025. Over the same period, quarterly EPS has...

Aegon (ENXTAM:AGN) has just released its FY 2025 numbers, reporting second half revenue of €2.9 billion, basic EPS of €0.24 and net income of €362 million, set against trailing twelve month EPS of €0.59 and net income of €927 million. The company has seen revenue move from €6.4 billion and EPS of €0.44 in the second half of 2024 to €6.7 billion and EPS of €0.36 in the first half of 2025. Over the same period, trailing twelve month revenue has shifted from €12.8 billion with EPS of €0.37 to...

Rani Zim Shopping Centers (TASE:RANI) has released its FY 2025 figures, with the latest quarter showing revenue of ₪43.8m and net income of ₪9.1m, equal to EPS of ₪0.05. The trailing 12 months reflect a net profit margin of 15.4% compared with 47.3% a year earlier. Over recent quarters the company has seen revenue move from ₪66.8m in Q3 2024 to ₪56.3m in Q1 2025, then to ₪101.0m in Q2 2025 and ₪43.8m in Q3 2025. EPS shifted from ₪0.59 to a loss of ₪0.06, then ₪0.16 and ₪0.05, as a one-off...

Verra Mobility, NasdaqCM:VRRM, is reporting long term sales growth alongside pressure on free cash flow margins. Recent quarterly results show weaker profitability, prompting questions about investment needs and cost control. Investor sentiment has cooled, with the share price at $13.88 and a 37.8% decline year to date. For shareholders, the story around Verra Mobility is no longer just about sales momentum. The stock is down 37.8% year to date and 31.3% over the past year, with the current...

In March 2026, Smithfield Foods reported higher fourth-quarter and full-year 2025 results, issued 2026 guidance for low-single-digit sales growth, announced a quarterly dividend of US$0.3125 per share, and outlined an agreement to acquire the Nathan's Famous packaged meats brand while continuing to evaluate additional M&A opportunities. A key takeaway for investors is Smithfield Foods’ record 2025 operating profit of US$1.30 billion and margin expansion to 8.6%, highlighting improved...

Spero Therapeutics (SPRO) closed FY 2025 with fourth quarter revenue of US$41.3 million and basic EPS of US$0.56, alongside trailing twelve month revenue of US$66.8 million and EPS of roughly US$0.15 that mark a shift into profitability over the period. Over recent quarters, the company has seen revenue range from US$5.4 million to US$41.3 million with quarterly EPS moving from a loss of about US$0.25 per share at the start of FY 2025 to a profit in the latest quarter, providing a clearer...